A retrospective cohort study comparing the laser photocoagulation and intravitreal injection of Bevacizumab treatment for Retinopathy of prematurity
Latest Information Update: 07 Sep 2021
At a glance
- Drugs Bevacizumab (Primary)
- Indications Retinopathy of prematurity
- Focus Adverse reactions; Therapeutic Use
- 07 Sep 2021 New trial record
- 01 Sep 2021 Results published in the Graefes Archive for Clinical and Experimental Ophthalmology